Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia

Addition of the immunomodulator pentoxifylline (PTX) to antimonial treatment of mucosal leishmaniasis has shown increased efficacy. This randomized, double-blind, placebo-controlled trial evaluated whether addition of pentoxifylline to meglumine antimoniate (MA) treatment improves therapeutic respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Maria del Mar, Cossio, Alexandra, Navas, Adriana, Fernandez, Olga, Valderrama, Liliana, Cuervo-Pardo, Lyda, Marquez-Oñate, Ricardo, Gómez, María Adelaida, Saravia, Nancy Gore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949591/
https://www.ncbi.nlm.nih.gov/pubmed/35335703
http://dx.doi.org/10.3390/pathogens11030378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949591/
https://www.ncbi.nlm.nih.gov/pubmed/35335703
http://dx.doi.org/10.3390/pathogens11030378

Ejemplares similares